|Articles|April 8, 2012
What Does Overturning ACA Mean to Pharma?
Author(s)Christopher Allen
In contentious three days of hearing on the Affordable Care Act, the Supreme Court now seems far more likely to overturn the landmark legislation.
Advertisement
Guest blog written by Reid Paul.
In contentious three days of hearing on the Affordable Care Act, the Supreme Court now seems far more likely to overturn the landmark legislation. Given the strong support the bill originally received from the industry, does overturning it benefit or hurt pharma?
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Putting Sustainability to Work in Pharma
2
Managing Global Trial Supply Risk: Expert Insights
3
Why Oral Solid Dosage Validation Is a Business Continuity Function, Not Just a Compliance Requirement
4
Technology Transfer: Success Drivers and Obstacles Explained
5